Robin M, de Wreede LC, Padron E, et al. Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis. Blood. 2022;140(12):1408-1418.

In Table 3 on page 1415, some of the hazard ratios are incorrect. They should be as follows.

Age at diagnosis: 1.12, not .12

Lower-risk patients, Td AML: 5.14, not .14

Lower-risk patients, Td allo-HCT (without AML): 0-2 y: 3.19, not .19

Higher-risk patients, Td AML: 3.68, not .68

Higher-risk patients, Td allo-HCT (without AML): 0-2 y: 1.46, not .46